Back to DirectoryParenteral Nutrition
Parenteral Nutrition

Clinimix E 5/20 sulfite free w/ elect in dextrose 20% w/ calcium

Osmolarity: ≈ 1,780 mOsm/LTonicity: HypertonicpH: 5.0 – 6.5 Central Line Required

Clinical Indications

Concentrated high-protein, high-calorie TPN for fluid-restricted hypermetabolic patients. ICU and oncology settings where volume limitation is critical.

Dosing & Administration Rate

High caloric density — small volume per day meets full nutritional requirements. Monitor glucose, electrolytes, and liver function closely.

Warnings & Precautions

Very high osmolarity — central access mandatory. Strict glucose management with insulin protocol. Standard TPN safety monitoring.

Contraindications

Known hypersensitivity to amino acids. Severe liver disease or hepatic coma. Severe renal impairment (without dialysis). Abnormalities of amino acid metabolism.

Pharmacology & Safety Profile

Mechanism of Action

Provides a source of biologically utilizable essential and non-essential amino acids for protein synthesis, and dextrose as a source of calories.

Adverse Reactions

Phlebitis, fluid overload, hyperglycemia, hyperosmolar syndrome, electrolyte imbalances, metabolic acidosis, liver enzyme elevations.

Compatibility Notes

CVC. Vitamins and trace elements per protocol.

Electrolyte & Composition Profile

ComponentAmount / Concentration
Amino Acids50 g/L (5%)
Dextrose (Anhydrous)200 mg/mL (20%)
Electrolytes (Na, K, Ca, Mg, Phosphate)Standard Clinimix E panel
Nitrogen Content≈ 7.7 g/L
Caloric Density≈ 1,280 kcal/L
Nitrogen Content7.7 g N/L

Clinical Parameters

RouteIntravenous (central venous access)
Fluid CategoryParenteral Nutrition
Required MonitoringVital signs, fluid intake/output, baseline electrolytes
Administration SetupDedicated central venous lumen.
Pregnancy SafetyCategory C (FDA). Animal reproduction studies have not been conducted. Should be given to a pregnant woman only if clearly needed.
StorageRoom temperature. Protect from freezing.
Prescription Status Rx Only

Clinical Disclaimer: Data compiled from FDA DailyMed, Baxter/Fresenius prescribing information, and USP monographs. Always verify against the physical product label, your institution's IV protocols, and current pharmacist guidance before administration.